$367 Million is the total value of DAFNA Capital Management LLC's 90 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 12.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Buy | SPDR SP BIOTECH ETFetf | $45,528,000 | +88.0% | 613,000 | +127.5% | 12.41% | +96.6% |
| STXS | STEREOTAXIS INC | $25,172,000 | -50.7% | 13,680,554 | 0.0% | 6.86% | -48.4% | |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $16,043,000 | +74.4% | 110,100 | +41.9% | 4.37% | +82.4% |
| ACET | Buy | ADICET BIO INC | $13,662,000 | -4.4% | 935,766 | +30.7% | 3.72% | -0.0% |
| FATE | Buy | FATE THERAPEUTICS INC | $13,652,000 | -29.7% | 550,940 | +10.0% | 3.72% | -26.5% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $13,343,000 | +14.8% | 438,623 | +15.4% | 3.64% | +20.1% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $13,197,000 | -16.1% | 261,280 | +6.1% | 3.60% | -12.2% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $12,941,000 | +260.2% | 139,212 | +354.8% | 3.53% | +276.8% |
| IBB | ISHARES TR NASDAQ BIOTECH INDXetf | $12,057,000 | -9.7% | 102,500 | 0.0% | 3.29% | -5.6% | |
| CYTK | CYTOKINETICS INC | $8,310,000 | +6.7% | 211,495 | 0.0% | 2.26% | +11.6% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $8,057,000 | +2.7% | 82,655 | -1.2% | 2.20% | +7.4% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $7,850,000 | -24.5% | 62,053 | -24.4% | 2.14% | -21.1% |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $7,570,000 | +38.0% | 548,561 | +11.9% | 2.06% | +44.4% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $7,180,000 | -5.7% | 566,695 | +4.3% | 1.96% | -1.3% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $7,138,000 | +10.4% | 370,987 | -0.3% | 1.94% | +15.4% |
| MRUS | Buy | MERUS N V | $5,952,000 | -4.2% | 262,891 | +11.9% | 1.62% | +0.2% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $5,843,000 | -1.3% | 299,785 | +29.2% | 1.59% | +3.2% |
| SAGE | SAGE THERAPEUTICS INC | $5,824,000 | -2.4% | 180,306 | 0.0% | 1.59% | +2.1% | |
| ALEC | Buy | ALECTOR INC | $5,613,000 | +34.5% | 552,438 | +88.7% | 1.53% | +40.8% |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $5,540,000 | +60.1% | 695,959 | +95.1% | 1.51% | +67.4% |
| DXCM | Buy | DEXCOM INC | $5,407,000 | -41.7% | 72,552 | +300.0% | 1.47% | -39.0% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $5,344,000 | +52.2% | 79,600 | +86.4% | 1.46% | +59.2% |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $5,273,000 | +0.2% | 1,787,569 | +5.6% | 1.44% | +4.7% |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $4,757,000 | +3.8% | 187,717 | +29.3% | 1.30% | +8.6% |
| NTUS | Sell | NATUS MEDICAL INC | $4,706,000 | -6.1% | 143,600 | -24.7% | 1.28% | -1.7% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $4,383,000 | -8.2% | 96,935 | +3.2% | 1.20% | -3.9% |
| MORF | Buy | MORPHIC HLDG INC | $4,242,000 | -41.8% | 195,467 | +7.7% | 1.16% | -39.1% |
| CSII | CARDIOVASCULAR SYS INC | $4,121,000 | -36.5% | 286,988 | 0.0% | 1.12% | -33.6% | |
| IPSC | Buy | CENTURY THERAPEUTICS INC | $3,993,000 | +23.5% | 475,367 | +85.0% | 1.09% | +29.1% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,916,000 | +0.6% | 4,000,000 | 0.0% | 1.07% | +5.2% | ||
| ISEE | Buy | IVERIC BIO INC | $3,872,000 | -22.9% | 402,476 | +34.8% | 1.06% | -19.4% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $3,646,000 | +128.4% | 48,452 | -18.5% | 0.99% | +138.9% |
| FSTX | Sell | F-STAR THERAPEUTICS INC | $3,611,000 | +46.6% | 576,881 | -16.9% | 0.98% | +53.3% |
| OTIC | Sell | OTONOMY INC | $3,058,000 | -14.9% | 1,470,199 | -1.8% | 0.83% | -11.0% |
| ATRC | ATRICURE INC | $2,943,000 | -37.8% | 72,029 | 0.0% | 0.80% | -34.9% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $2,830,000 | +69.7% | 224,451 | +51.5% | 0.77% | +77.2% |
| AXGN | AXOGEN INC | $2,720,000 | +3.1% | 332,103 | 0.0% | 0.74% | +7.9% | |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $2,614,000 | -7.0% | 265,663 | +39.3% | 0.71% | -2.7% |
| ETNB | Buy | 89BIO INC | $2,469,000 | +102.0% | 766,774 | +136.6% | 0.67% | +111.6% |
| Buy | DICE THERAPEUTICS INC | $2,435,000 | +35.4% | 156,904 | +66.9% | 0.66% | +41.6% | |
| GLPG | GALAPAGOS NVspon adr | $2,381,000 | -10.0% | 42,675 | 0.0% | 0.65% | -5.9% | |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $2,202,000 | -5.7% | 131,200 | +146.6% | 0.60% | -1.3% |
| AERI | AERIE PHARMACEUTICALS INC | $2,168,000 | -17.6% | 289,040 | 0.0% | 0.59% | -13.7% | |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $2,169,000 | -24.5% | 105,298 | +17.9% | 0.59% | -21.1% |
| KURA | Buy | KURA ONCOLOGY INC | $2,160,000 | +18.6% | 117,829 | +4.0% | 0.59% | +24.0% |
| AFMD | Buy | AFFIMED N V | $1,901,000 | -23.9% | 686,282 | +20.1% | 0.52% | -20.4% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $1,879,000 | +33.5% | 406,763 | +15.3% | 0.51% | +39.5% |
| ORIC | New | ORIC PHARMACEUTICALS INC | $1,863,000 | – | 415,926 | +100.0% | 0.51% | – |
| ARAY | ACCURAY INC | $1,846,000 | -40.8% | 941,800 | 0.0% | 0.50% | -38.1% | |
| SURF | Buy | SURFACE ONCOLOGY INC | $1,804,000 | -9.8% | 1,100,000 | +61.8% | 0.49% | -5.6% |
| BMEA | Sell | BIOMEA FUSION INC | $1,640,000 | -4.2% | 136,935 | -64.3% | 0.45% | +0.2% |
| Sell | FIELD TRIP HEALTH LTD | $1,600,000 | -45.5% | 1,904,141 | -13.1% | 0.44% | -43.0% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $1,404,000 | -32.1% | 496,150 | 0.0% | 0.38% | -28.9% | |
| Buy | PARDES BIOSCIENCES INC | $1,385,000 | -54.5% | 451,105 | +7.1% | 0.38% | -52.4% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $1,380,000 | -16.0% | 107,653 | 0.0% | 0.38% | -12.1% | |
| VKTX | Buy | VIKING THERAPEUTICS INC | $1,336,000 | -0.4% | 462,400 | +3.4% | 0.36% | +4.0% |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,292,000 | -3.9% | 1,500,000 | 0.0% | 0.35% | +0.6% | ||
| MREO | Sell | MEREO BIOPHARMA GROUP PLCads | $1,228,000 | -9.9% | 1,096,513 | -9.9% | 0.34% | -5.6% |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $1,210,000 | +55.1% | 372,361 | -4.6% | 0.33% | +62.6% |
| New | REGULUS THERAPEUTICS INC | $1,150,000 | – | 555,555 | +100.0% | 0.31% | – | |
| KROS | New | KEROS THERAPEUTICS INC | $1,078,000 | – | 39,000 | +100.0% | 0.29% | – |
| MEIP | MEI PHARMA INC | $1,069,000 | +0.4% | 1,767,146 | 0.0% | 0.29% | +4.7% | |
| STIM | NEURONETICS INC | $1,007,000 | +5.9% | 313,717 | 0.0% | 0.27% | +10.5% | |
| BWAY | BRAINSWAY LTDsponsored ads | $966,000 | -44.7% | 200,000 | 0.0% | 0.26% | -42.2% | |
| RDUS | Sell | RADIUS HEALTH INC | $953,000 | -43.8% | 91,935 | -52.1% | 0.26% | -41.2% |
| NXTC | NEXTCURE INC | $882,000 | -3.3% | 187,696 | 0.0% | 0.24% | +0.8% | |
| SCYX | Buy | SCYNEXIS INC | $845,000 | +78.3% | 454,492 | +274.9% | 0.23% | +85.5% |
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $810,000 | -16.1% | 74,890 | 0.0% | 0.22% | -12.0% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $771,000 | -11.3% | 313,600 | 0.0% | 0.21% | -7.1% | |
| GNFT | GENFIT S Aads | $605,000 | -19.5% | 187,940 | 0.0% | 0.16% | -15.8% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $597,000 | -17.4% | 351,064 | 0.0% | 0.16% | -13.3% | |
| MGNX | MACROGENICS INC | $566,000 | -66.5% | 192,000 | 0.0% | 0.15% | -65.1% | |
| GHRS | GH RESEARCH PLCordinary shares | $549,000 | -45.4% | 55,000 | 0.0% | 0.15% | -42.7% | |
| CMPX | Buy | COMPASS THERAPEUTICS INC | $525,000 | +95.2% | 198,094 | +1.0% | 0.14% | +104.3% |
| Buy | THESEUS PHARMACEUTICALS INC | $453,000 | -51.0% | 81,899 | +2.2% | 0.12% | -49.0% | |
| VERO | VENUS CONCEPT INC | $449,000 | -67.6% | 968,187 | 0.0% | 0.12% | -66.2% | |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $441,000 | -83.5% | 390,066 | -56.5% | 0.12% | -82.8% |
| STRO | SUTRO BIOPHARMA INC | $441,000 | -36.6% | 84,700 | 0.0% | 0.12% | -33.7% | |
| MASI | MASIMO CORP | $392,000 | -10.3% | 3,000 | 0.0% | 0.11% | -6.1% | |
| CGEN | Buy | COMPUGEN LTDord | $380,000 | -9.3% | 205,202 | +57.6% | 0.10% | -4.6% |
| LVTX | Sell | LAVA THERAPEUTICS NV | $379,000 | -38.2% | 128,335 | -7.9% | 0.10% | -35.6% |
| INGN | INOGEN INC | $363,000 | -25.3% | 15,000 | 0.0% | 0.10% | -22.0% | |
| VIGIL NEUROSCIENCE INC | $257,000 | -63.3% | 99,754 | 0.0% | 0.07% | -61.7% | ||
| PHAS | PHASEBIO PHARMACEUTICALS INC | $227,000 | -54.6% | 378,611 | 0.0% | 0.06% | -52.3% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $222,000 | -27.0% | 3,100 | 0.0% | 0.06% | -22.8% | |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $221,000 | +2.3% | 140,000 | 0.0% | 0.06% | +7.1% | |
| CNTB | New | CONNECT BIOPHARMA HLDGS LTDads | $218,000 | – | 250,000 | +100.0% | 0.06% | – |
| ASLN | Buy | ASLAN PHARMACEUTICALS LTDads | $170,000 | -22.4% | 343,720 | +41.0% | 0.05% | -19.3% |
| ANNX | Buy | ANNEXON INC | $154,000 | +83.3% | 40,796 | +32.5% | 0.04% | +90.9% |
| LRMR | LARIMAR THERAPEUTICS INC | $98,000 | -51.5% | 49,996 | 0.0% | 0.03% | -49.1% | |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -120,097 | -100.0% | -0.04% | – |
| SRGA | Exit | SURGALIGN HOLDINGS INC | $0 | – | -579,710 | -100.0% | -0.05% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -105,163 | -100.0% | -0.14% | – |
| PHVS | Exit | PHARVARIS N V | $0 | – | -34,615 | -100.0% | -0.16% | – |
| IMCR | Exit | IMMUNOCORE HOLDINGS PLCads | $0 | – | -53,878 | -100.0% | -0.42% | – |
| RGLS | Exit | REGULUS THERAPEUTICS INC | $0 | – | -5,555,555 | -100.0% | -0.43% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -223,554 | -100.0% | -0.44% | – |
| ATHA | Exit | ATHIRA PHARMA INC | $0 | – | -160,983 | -100.0% | -0.57% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.